Hepatic Clinical Trials in Shanghai, Shanghai Municipality
14 recruitingShanghai, Shanghai Municipality, China
Showing 1–14 of 14 trials
Recruiting
Phase 2
Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases
Pancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer
Ruijin Hospital50 enrolled1 locationNCT07504471
Recruiting
Incidence of Liver Disease-Related Outcomes in People With HIV
Liver FibrosisHIVHepatic Steatosis+3 more
Shanghai Public Health Clinical Center320 enrolled2 locationsNCT06940375
Recruiting
Not Applicable
LISH Trial for the Hepatic Flexure and Proximal Transverse Colon Cancer
Hepatic Flexure Colon CancerProximal Transverse Colon Cancer
Zhejiang University568 enrolled29 locationsNCT05923255
Recruiting
Phase 1
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
Hepatic Cell Carcinoma
Shanghai Ruiliyuan Biotechnology Co., Ltd.12 enrolled1 locationNCT06515314
Recruiting
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
ctDNAGall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)+3 more
Yingbin Liu, MD, PhD, FACS1,800 enrolled1 locationNCT07176962
Recruiting
Phase 2
Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma (Icc)
Fudan University56 enrolled1 locationNCT07070700
Recruiting
Early Phase 1
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients
Intrahepatic Cholangiocarcinoma
Shanghai Changzheng Hospital9 enrolled1 locationNCT06583993
Recruiting
Phase 3
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
Intrahepatic Cholangiocarcinoma
Shanghai Junshi Bioscience Co., Ltd.480 enrolled1 locationNCT05342194
Recruiting
Phase 2
Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01)
Intrahepatic Cholangiocellular Carcinoma
Fudan University92 enrolled1 locationNCT06860477
Recruiting
Phase 2
TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
Fudan University25 enrolled1 locationNCT04954781
Recruiting
Phase 2
Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer
Intrahepatic Cholangiocarcinoma
Fudan University25 enrolled1 locationNCT05010681
Recruiting
Phase 2
Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer
Neoplasm MetastasisPancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer
Ruijin Hospital40 enrolled1 locationNCT06538623
Recruiting
Phase 2
HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC
Intrahepatic Cholangiocarcinoma
Fudan University45 enrolled1 locationNCT06335927
Recruiting
Not Applicable
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University168 enrolled13 locationsNCT04078230